Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

China Pharma Holdings (CPHI) Shares Outstanding (2016 - 2025)

China Pharma Holdings (CPHI) has disclosed Shares Outstanding for 16 consecutive years, with $5.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding rose 181.19% year-over-year to $5.0 million, compared with a TTM value of $5.0 million through Sep 2025, up 181.19%, and an annual FY2024 reading of $3.3 million, up 206.98% over the prior year.
  • Shares Outstanding was $5.0 million for Q3 2025 at China Pharma Holdings, up from $3.3 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $45.6 million in Q1 2021 and bottomed at $1.1 million in Q4 2023.
  • Average Shares Outstanding over 5 years is $8.6 million, with a median of $3.3 million recorded in 2025.
  • The sharpest move saw Shares Outstanding tumbled 89.4% in 2022, then surged 206.98% in 2024.
  • Year by year, Shares Outstanding stood at $4.7 million in 2021, then tumbled by 68.35% to $1.5 million in 2022, then dropped by 29.08% to $1.1 million in 2023, then soared by 206.98% to $3.3 million in 2024, then soared by 53.96% to $5.0 million in 2025.
  • Business Quant data shows Shares Outstanding for CPHI at $5.0 million in Q3 2025, $3.3 million in Q2 2025, and $3.3 million in Q1 2025.